Iktos, announced a research collaboration with Zealand Pharma A/S to co-develop generative and predictive AI technologies for peptide drug design. Under the agreement, Zealand will contribute its expertise in peptide drug discovery to Iktos' generative modelling technologies and expertise in machine learning and AI.